Results 11 to 20 of about 33,349 (194)
Prices of paediatric vaccines in European vaccination programmes
Vaccine: X, 2023 Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe.
Heini Salo +6 more
doaj +1 more source
PLoS Pathogens, 2020 High-risk human papillomaviruses (HPVs) cause 5% of human cancers. Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals ...
Wei Wang +9 more
doaj +1 more source
Prophylactic HPV vaccines [PDF]
Archive of Oncology, 2009 Human papillomavirus (HPV) is one of the most common sexually transmitted diseases worldwide. Cervical and other anogenital cancers, cervical and anal intraepithelial neoplasia, genital warts, and recurrent respiratory papillomatosis are HPV associated ...
Mandić Aljoša
doaj +1 more source
Global challenges of implementing human papillomavirus vaccines
International Journal for Equity in Health, 2011 Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable.
Mishra Amrita, Graham Janice E
doaj +1 more source
Novel Antigenic Targets of HPV Therapeutic Vaccines
Vaccines, 2021 Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical ...
Ditte Rahbæk Boilesen +2 more
doaj +1 more source
Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection [PDF]
Human Vaccines and Immunotherapeutics, 2018 Martin Tolstrup +2 more
exaly +2 more sources
Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
Acta Médica Portuguesa, 2020 Introduction: Human papillomavirus is responsible for almost all cases of cervical cancer, an important portion of anogenital and oropharyngeal invasive and preinvasive lesions, as well as genital warts (condyloma acuminatum) and recurrent respiratory ...
Rita Medeiros +3 more
doaj +1 more source
A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]
PLoS ONE, 2015 Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel +5 more
doaj +1 more source
Eliminat Cervical Cancer, Focusing on Primary Prevention
Zhongliu Fangzhi Yanjiu, 2023 As one of the most severe malignant tumors, cervical cancer poses a significant threat to women. In 2020, the World Health Organization (WHO) introduced the "Global Strategy to Accelerate the Elimination of Cervical Cancer" in response to well ...
ZHAO Chao, LI Mingzhu, WEI Lihui
doaj +1 more source
Proceedings of Singapore Healthcare, 2017 Introduction: Although cervical cancer is the 10th most common cancer among females in Singapore, it is a vaccine-preventable cancer. Human papillomavirus vaccines combined with regular Pap (papillomavirus) smears have been shown to reduce the mortality ...
Sarah Woon Ching Lim +9 more
doaj +1 more source